• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Eur Respir J. Severe influenza A H7N9 pneumonia with rapid virological response to intravenous zanamivir.

Giuseppe

Emeritus
[Source: US National Library of Medicine, full page: (LINK). Abstract, edited.]


Eur Respir J. 2014 Apr 2. [Epub ahead of print]

Severe influenza A H7N9 pneumonia with rapid virological response to intravenous zanamivir.

Ho PL<SUP>1</SUP>, Sin WC, Chan JF, Cheng VC, Chan KH.

Author information: <SUP>1</SUP>University of Hong Kong, Hong Kong, China.


Abstract

To the Editor:

In March 2013, a novel influenza A H7N9 virus of avian origin was reported to cause severe pneumonia in mainland China <SUP>1-3</SUP>. While the great majority of patients were treated with oral oseltamivir, impaired gastrointestinal absorption in critically ill patients, the lack of virological response among patients requiring extracorporeal membrane oxygenation (ECMO) and detection of an amino acid change (arginine to lysine at residue 292 in N2) in the viral neuraminidase associated with drug resistance in two H7N9 strains are major concerns <SUP>1, 4</SUP>. Here, we report a case of severe pneumonia due to avian influenza A H7N9 requiring ECMO support; there was rapid clinical and virological response following intravenous zanamivir therapy.On November 21, 2013, in Hong Kong, China, a 36-year-old Indonesian female began to have fever, malaise and cough. She had been previously healthy except for a history of vitiligo. She sought medical advice from two clinics and was given symptomatic treatment. She attended the accident and emergency department of a regional hospital in Hong Kong on November 27 when the symptoms deteriorated. Her temperature was 40.0?C, blood pressure.


PMID: 24696114 [PubMed - as supplied by publisher]


-
------
 
Back
Top Bottom